PDL Biopharma, Inc. operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares PDL Biopharma with three other
companies in this sector in UNITED STATES :
Twist Bioscience Corp
sales of $54.39 million
of which 40%
was Industrial chemicals),
Apollo Endosurgery Inc
of which 56%
was Endo bariatric-ESS), and
Protalix Biotherapeutics Inc
of which 100%
was Biotherapeutic Products).
Sales fell dramatically in 2019:
PDL Biopharma reported sales of $54.76 million
December of 2019.
decrease of 72.4%
versus 2018, when the company's sales were $198.11 million.
Contributing to the drop in overall sales was the 31.8% decline
in Pharmaceutical, from $80.80 million to $55.09 million.
However, these declines were partially offset by the increase in sales of
Medical Devices (up 24.7% to $30.74 million)